1.The characteristics of current blood components and blood donations at asan medical center.
Moon Ho LEE ; Eul Ju SEO ; Dae Won KIM ; Byung Yoon BAIK ; Young Chul OH ; Ki Hong KIM
Korean Journal of Blood Transfusion 1993;4(1):1-6
No abstract available.
Blood Donors*
;
Chungcheongnam-do*
;
Humans
2.Clinical Features of Hypersensitivity Reactions to Cisplatin and Carboplatin.
Yeon Jin PARK ; Eul Ju MOON ; Hee Hwahn CHUNG ; Ju Won ROH ; Sang Yoon PARK ; Young Suk PARK
Korean Journal of Obstetrics and Gynecology 2003;46(5):1018-1023
OBJECTIVE: To characterize the clinical features of platinum compounds (cisplatin plus carboplatin) associated hypersensitivity reactions. METHODS: Medical records of 102 patients with gynecologic malignancy who received chemotherapy based on platinum at Center for Uterine Cancer from Jun. 2001 to Nov. 2002 were analyzed. Platinum hypersensitivity reaction was classified as acute and delayed reaction according to the time of onset, also mild and severe reaction according to the severity of symptoms and signs. RESULTS: Among the 102 patients treated with platinum compounds during this period, 20 (20%) developed hypersensitivity reaction. The median number of platinum courses for the first episode was 7 (range 4-9) and it concentrated at 7, 8, 9th cycles. Fourteen patients developed acute reaction and six patients experienced delayed reaction. Ten patients experienced severe symptoms including dyspnea. Acute reaction developed from a few minutes to 30 minutes after the initiation of the platinum infusion. Delayed reaction developed after discharge of patients with mild intensity. CONCLUSION: Platinum hypersensitivity reactions develop in patients who have been extensively pre- treated with these agents. As platinum compounds are increasingly used as neoadjuvant, initial, second-line chemotherapy of ovarian cancer and concurrent chemoradiation, palliative setting of cervical cancer, it can be anticipated that hypersensitivity reactions to these drugs will happen more frequently, at the same time it might be a important issue for clinicians engaged in chemotherapy.
Carboplatin*
;
Cisplatin*
;
Drug Therapy
;
Dyspnea
;
Humans
;
Hypersensitivity*
;
Medical Records
;
Ovarian Neoplasms
;
Platinum
;
Platinum Compounds
;
Uterine Cervical Neoplasms
;
Uterine Neoplasms
3.FDG-PET Scan in Patients with Pelvic Recurrence of Cervical Cancer.
Yeon Jin PARK ; Eul Ju MOON ; Hee Hwahn CHUNG ; Ju Won ROH ; Sang Yoon PARK ; Keon Wook KANG
Korean Journal of Obstetrics and Gynecology 2003;46(5):991-997
OBJECTIVE: The purpose of this study was to investigate the clinical feasibility of FDG-PET scan in selection of patients with pelvic recurrence of cervical cancer for surgical treatment. METHODS: From Jun. 2001 to Oct. 2002, whole body FDG-PET scan findings were compared with findings of CT, MRI, and pathologic reports in 24 patients with pelvic recurrence of cervical cancer. PET scan was obtained with a GE Advance PET scanner, beginning at 60 minutes after injection of 370-555 MBq (10- 15 mCi) of 18F FDG. Regional scan was also obtained if needed. Uptake exceeding 2.5 SUV was determined as a positive finding. RESULTS: Among these 24 patients, 10 patients had metastatic lesions at pelvic lymphnodes (4), para- aortic lymphnodes (3), mediastinal lympnnodes (1), lung (4), and bone (1). Among 14 patients with no metastasis, 10 patients underwent surgical treatment but the operations were abandoned in 2 patients due to lymphnodes metastasis and pelvic peritoneal spreads that confused as normal FDG uptake of the intestines pre- operatively. Among 8 patients whom the operation was completed, 3 patients received pelvic exenteration, 2 patients received CORT, and 3 patients received LEER. CONCLUSION: FDG-PET is clinically feasible in selection of patients with pelvic recurrence of cervical cancer for surgical treatment.
Humans
;
Intestines
;
Lung
;
Magnetic Resonance Imaging
;
Neoplasm Metastasis
;
Pelvic Exenteration
;
Positron-Emission Tomography
;
Recurrence*
;
Uterine Cervical Neoplasms*
4.A Case of Liver Infarction after a Histoacryl R Injection for Duodenal Ulcer Bleeding.
Hye Rang KIM ; Young Sook PARK ; Young Soo MOON ; Sung Bae LEE ; Young Hoon KIM ; Keun Man LEE ; Myeong Ju CHOI ; Sun Hee KIM
Korean Journal of Gastrointestinal Endoscopy 1999;19(4):629-633
Injection of the tissue adhesive Histoacryl (N-butyl-2-cyanoacrylate, enbucrilate) has been more effective than conventional sclerosants in the treatment of active upper G-I bleeding. Histoacryl is an effective sclerosant that is polymerized immediately after contact with blood, and has been used for the treatment of bleeding gastric and esophageal varices. We present here a case of infarction of the caudate lobe that developed after an injection of a Histoacryl -Lipiodol mixture for the hemostasis of duodenal ulcer bleeding.
Duodenal Ulcer*
;
Enbucrilate*
;
Esophageal and Gastric Varices
;
Hemorrhage*
;
Hemostasis
;
Infarction*
;
Liver*
;
Polymers
;
Sclerosing Solutions
;
Tissue Adhesives
5.A Case of Fenestrated Basilar Artery Associated with Multiple Aneurysms.
Dong Hyun KYUNG ; Hee In KANG ; Byung Gwan MOON ; Seung Jin LEE ; Ju Seung KIM ; In Kyu YOO
Journal of Korean Neurosurgical Society 1999;28(10):1529-
Fenestrated basilar artery is a uncommon congenital anomaly. It is seen in approximately 0.3 to 5.26% of autopsy series, but only in 0.1 to 1.9% of angiography series. Because the fenestrated basilar artery is a defect or weakness of muscular and internal elastic lamina, incidence of fenestration of the basilar artery when a vertebrobasilar artery aneurysm is present is reported to be 35.5%. We experienced one case of fenestrated basilar artery associated with multiple aneurysms(fenestrated basilar artery, basilar tip, left posterior communicating artery). We operated the basilar tip aneurysm and the posterior communicating artery aneurysm. Although we didn't operate the fenestrated basilar artery aneurysm, we report one case with review of literature in order to improve the operative result of the fenestrated basilar artery aneurysm.
Aneurysm*
;
Angiography
;
Arteries
;
Autopsy
;
Basilar Artery*
;
Incidence
;
Intracranial Aneurysm
6.A Case of Malignant Mixed M llerian Tumor of the Fallopian Tube.
Woo Jin JEON ; Eul Ju MOON ; Jae Soo KOH ; Sang Young RYU ; Jong Hoon KIM ; Byoung Gie KIM ; Sang Yoon PARK ; Kyeong Hee LEE
Korean Journal of Obstetrics and Gynecology 2000;43(10):1848-1852
No abstract available.
Fallopian Tubes*
;
Female
7.Detection of Minimal Residual Disease by IgH gene rearrangement-PCR in Childhood Acute Lymphoblastic Leukemia.
Chan Jeoung PARK ; Mi Chong KIM ; Ae Ran MOON ; Eul Ju SEO ; Hyun Sook CHI ; Jong Jin SEO ; Tae Hyung KIM ; Hyung Nam MOON
Korean Journal of Clinical Pathology 1999;19(2):163-171
BACKGROUND: The IgH gene rearrangement (IgH GR) involving highly specific CDR3 region can be used as a minimal residual disease marker in ALL. The IgH GR-PCR has the advantages of the high positive rate in ALL and the detection of clonal evolution. METHODS: In 30 cases of childhood ALL, the DNA was extracted from the bone marrow aspirates at the diagnosis and during the chemotherapy. The 40 cycle polymerase chain reaction was performed with seven each VH family specific primer and common JH primer. The PCR products were electrophoresed on the agarose gel, and those showing specific bands were electrophoresed on 6M urea 6% polyacrylamide DNA sequencing gel. We compared and analyzed the IgH GR-PCR results, the morphologic diagnosis of the bone marrow and the clinical course. RESULTS: IgH GR was detected in 93.3% (28/30) at the diagnosis and the rest of two cases showed IgH GR during the therapy. IgH GR was detected in all specimens diagnosed as persistence, partial remission and relapse, the 80.0% of hypocellular marrow with persistence of blasts, the 72.7% of hypocellular marrow, and the 59.2% of complete remission. In the complete remission states the patients with IgH GR showed significantly higher relapse rate (26.2%) than those without IgH GR (7.1%) (p=0.019). Number of clones of IgH GR was from one to five. The more number of clones showed the shorter mean survival time (p=0.1172). The usage of VH3 was most frequent (70.0%). IgH GR had been detected average 3.5 months (range 1-12 months) earlier than the morphologic relapse appeared. During the chemotherapy the evolution of IgH GR was observed in the seven cases (23.3%). CONCLUSIONS: The IgH GR-PCR will help the understanding of biological characteristics of leukemic cells, the interpretation of the bone marrow studies after chemotherapy and the plans of further therapy, and can be used as a prognostic indicator in the morphologic complete remission state.
Bone Marrow
;
Clonal Evolution
;
Clone Cells
;
Diagnosis
;
DNA
;
Drug Therapy
;
Gene Rearrangement
;
Humans
;
Neoplasm, Residual*
;
Polymerase Chain Reaction
;
Population Characteristics
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
;
Recurrence
;
Sepharose
;
Sequence Analysis, DNA
;
Survival Rate
;
Urea
8.A Case of Well-differentiated Papillary Mesothelioma Developing Malignant Mesothelioma with Seeding Mass on the Trocar Insertion Site of Diagnostic Laparoscopy and Malignant Change.
Min Jung KIM ; Eul Ju MOON ; Yeon Jin PARK ; Ju Won ROH ; Young Suk PARK ; So Yeon PARK ; Hee Sung KIM ; Jung Suk SIM ; Sang Yoon PARK
Cancer Research and Treatment 2001;33(4):357-361
Although well-differentiated papillary mesothelioma (WDPM) is usually classified as benign, the natural history of this lesion has not been clearly established. We present a case of WDPM in 60-year old woman developing malignant mesothelioma with seeding mass on the trocar insertion site over a period of 2 years. The initial symptom exhibited by the patient was abdominal distension from massive ascitic fluid. With an impression of peritoneal carcinomatosis, we performed a diagnostic laparoscopy. On the laparoscopic finding, a small whitish nodule was found on the liver surface and the pathologic result revealed reactive mesothelial hyperplasia. At exploro-laparotomy, multiple small nodules were found on the omentum and a biopsy revealed well-differentiated papillary mesothelioma of the peritoneum. The patient underwent pelvic lymphadenectomy and omentectomy of the colon and was followed for 2 years without any further treatment. Subsequently, she presented with abdominal distention with massive ascites and palpable abdominal wall mass at the previous trocar insertion site. Malignant mesothelioma was confirmed histologically via re- exploration. The rare transformation of well-differentiated papillary mesothelioma into a typically malignant diffuse mesothelioma and the unusual seeding on trocar insertion site prompted us to report this case.
Abdominal Wall
;
Ascites
;
Ascitic Fluid
;
Biopsy
;
Carcinoma
;
Colon
;
Female
;
Humans
;
Hyperplasia
;
Laparoscopy*
;
Liver
;
Lymph Node Excision
;
Mesothelioma*
;
Middle Aged
;
Natural History
;
Omentum
;
Peritoneum
;
Surgical Instruments*
9.A Case of Endometrial Stromal Sarcoma with Smooth Muscle Differentiation.
Si Eun LEE ; Eul Ju MOON ; Yeon Jin PARK ; Ju Won ROH ; Hee Sung KIM ; Jung Suk SIM ; Jong Du PARK ; Sang Yoon PARK
Korean Journal of Obstetrics and Gynecology 2001;44(11):2150-2154
Mixed endometrial stromal and smooth-muscle tumor is one of the uncommon forms of uterine sarcoma. Only a few cases of endometrial stromal tumors showing smooth muscle differentiation have been reported in the literature. We experienced a case of low grade endometrial stromal sarcoma with smooth muscle differentiation in a 44-year-old woman, so we report this case with brief review of literatures.
Adult
;
Endometrial Stromal Tumors
;
Female
;
Humans
;
Muscle, Smooth*
;
Sarcoma
;
Sarcoma, Endometrial Stromal*
10.Clinicopathologic Characteristics and Prognosis of Endometrial Cancer : A Study of 100 Cases.
Woo Jin JEON ; Eul Ju MOON ; Sang Young RYU ; Jong Hoon KIM ; Byoung Gie KIM ; Sang Yoon PARK ; Jae Kyu LEE ; Eui Don LEE ; Jong Sung LEE ; Kyung Hee LEE
Korean Journal of Obstetrics and Gynecology 2000;43(9):1616-1623
No abstract available.
Endometrial Neoplasms*
;
Female
;
Prognosis*